Patent details

Basic Information

Publication number:

EP1534727

PCT Application Number:

PCT/US/2003/024987

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037672813

PCT Publication Number:

WO/2004/012687

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2'-DEOXYTHYMIDINE

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES DE BETA-L-2'-DEOXYTHYMIDINE CRISTALLINE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON KRISTALLINEM BETA-L-2'-DESOXYTHYMIDIN

SPC Number:

Dates

Filing date:

06/08/2003

Grant date:

09/11/2016

EP Publication Date:

09/11/2016

PCT Publication Date:

12/02/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/06/2005

EP B1 Publication Date:

09/11/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/08/2017

Expiration date:

06/08/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/08/2003

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

STORER Richard

Address:

United Kingdom (GB)

2

Name:

JONAITIS David

Address:

United States (US)

Priority

Priority Number:

401318 P

Priority Date:

06/08/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

C07H 19/06;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages